Clinical Trial Update: Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)

View source ↗

Summary

Trial NCT01148238 investigating markers of autoimmune diabetes and treatment of latent autoimmune diabetes in adults (LADA) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diabetes Mellitus
• Latent Autoimmune Diabetes in Adults

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Autoimmune Diabetes | Status: WITHDRAWN